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Abstract  
Background 
Bipolar disorder is associated with attentional and processing abnormalities.  Such abnormalities are 
also seen in healthy subjects with sleep disruption.  We hypothesised cognitive abnormalities in 
bipolar disorder patients would be worse in those with objectively verified sleep abnormalities. 
Methods 
46 BD patients and 42 controls had comprehensive sleep/circadian rhythm assessment over 21 days 
alongside mood questionnaires. Cognitive function was assessed with a range of tasks including 
psychomotor vigilance test (PVT), Attention Network Task (ANT) and Digit Symbol Substitution Test 
(DSST). Bipolar disorder participants with normal and abnormal sleep were compared to age and sex 
matched controls. 
Results 
BD patients had longer response times and made more lapses (responses > 500ms) than controls on 
the PVT (both p<0.001).  However, patients with normal sleep patterns did not differ from controls 
while those with sleep abnormalities did (p<0.001).  An identical pattern of effects were seen with 
the ANT response times, with the abnormality in bipolar abnormal sleepers related to the executive 
attentional network.  Similarly, patients made fewer correct responses on the DSST compared to the 
controls (p<0.001). Bipolar normal sleepers did not differ while those with abnormal sleep did 
(p<0.001).  All these differences were seen in bipolar abnormal sleepers who were euthymic 
(p<0.01) and across the main abnormal sleep phenotypes. 
Conclusions 
We confirm impairment in attention and processing in bipolar disorder.  Rather than sleep 
abnormalities exacerbating such dysfunction, the abnormalities were confined to bipolar abnormal 
sleepers, consistent with sleep disturbance being the main driver of the cognitive abnormalities.  
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Introduction 
Bipolar disorder (BD) is associated with a range of well described cognitive dysfunctions as detailed 
in an individual patient data meta-analysis of 2876 subjects, with deficits seen across all cognitive 
domains tested (Bourne et al. 2013).  While cognitive dysfunction is modestly associated with a 
history of psychotic symptoms and mania, it is seen across all clinical subgroups (Bora 2018), 
including in patients when euthymic (Robinson et al. 2006;Thompson et al. 2005).  There is little 
evidence of progression of dysfunction over time (Samame et al. 2014).  The dysfunction may relate 
to underlying attentional and processing speed abnormalities (Gallagher et al. 2014).  The 
attentional abnormalities include increased intra-individual variability (IIV) in response times in 
attentional tasks (Gallagher et al. 2015).  Sleep disruption, a common feature of all stages of BD, 
including euthymia (Harvey et al. 2005), can also cause attentional abnormalities (Lim and Dinges 
2008).  Again this is associated with an increased IIV, most commonly reported as an increase of 
‘lapses’, or slow responses, in attentional tasks.  Primary sleep disorders, such as sleep apnoea, also 
impact on attention and alertness (Bucks et al. 2013) and are underdiagnosed in BD (Soreca et al. 
2015). Prior studies assessing cognition in patients with BD have rarely objectively assessed sleep 
alongside cognition and at best have relied upon self-report (Giglio et al. 2010;Kanady et al. 2017).  
There is a relative lack of correlation between objectively assessed and subjectively reported sleep 
abnormalities in bipolar disorder (Bradley et al. 2017;Harvey, Schmidt, Scarna, Semler, & Goodwin 
2005).  Therefore, there is an important lack of data describing the association between objectively 
measured sleep abnormalities and cognitive function in BD.  Previous work from this group 
objectively assessed sleep and circadian rhythm in detail in a well characterised cohort of BD 
patients (Bradley, Webb-Mitchell, Hazu, Slater, Middleton, Gallagher, McAllister-Williams, & 
Anderson 2017).  This revealed a range of sleep problems including obstructive sleep apnoea, 
circadian rhythm disturbance, hypersomnia and insomnia, with many patients having evidence of 
more than one of these disturbances.  These objectively measured sleep disturbances were 
associated with impaired psychosocial functioning and quality of life.  The aim of this study was to 
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assess the relationship between objectively assessed sleep and cognitive function in BD patients.  
Specifically this study has compared cognition in BD patients with and without abnormal sleep to age 
and sex matched controls.  Our hypothesis was that BD patients would demonstrate evidence of 
cognitive dysfunction and that this would be worse in, though not exclusive to, those patients with 
objectively verified sleep abnormalities. 
 
Method 
Participants 
The study was approved by the National Research Ethics Service Committee North East - Newcastle 
& North Tyneside.  Outpatients with BD type I or II, in any mood state, were recruited from a 
research database, patient support groups, and NHS services in the North East of England.  Healthy 
controls, matched by age and gender, were recruited from Newcastle University, local volunteer 
databases and hospital staff and their families.  All participants provided written informed consent 
before taking part in the research.  Participants were aged 18 to 65 years and fluent in English. 
Exclusion criteria were:  Any significant medical or neurological disorder that might interfere with 
sleep or cognition; current alcohol or substance misuse disorder (defined by DSM IV criteria 
(American Psychiatric Association 1994); current shift work and previous significant head injury.  A 
BD diagnosis meeting DSM-IV criteria was confirmed using the Mini International 
Neuropsychological Interview (MINI)(Sheehan et al. 1998).  Patients with BD were excluded if they 
had had any changes to their psychotropic medication in the previous 4 weeks.  Exclusion criteria for 
controls were: personal or first degree relative history of a DSM IV Axis I disorder as determined by 
clinical history; prescribed psychotropic medications and any known sleep disorder.  Additionally 
controls had to be psychiatrically well, confirmed by MINI interview; have a 17 item Hamilton 
Depression Rating Scale score (HAMD-17) (Hamilton 1967) score <7; a Young Mania Rating Scale 
(YMRS) (Young et al. 1978) score <5; a Pittsburgh sleep quality index (PSQI) (Buysse et al. 1989) score 
<5 and Epworth sleepiness scale (ESS) (Johns 1991) score <10. 
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Overall study design 
The study was cross-sectional, with participants assessed over a three week period. 
Psychiatric Symptoms and Sleep Assessments 
Participants were assessed on days 1 and 21. A comprehensive battery of questionnaires and rating 
scales were used to assess psychiatric symptoms.  These included the 17 item GRID-HAMD (Williams 
et al. 2008), Beck Depression Inventory (BDI) (Beck et al. 1961) and YMRS (Young, Biggs, Ziegler, & 
Meyer 1978).  All medications used by the patients in the BD group were recorded.  
A single night of home partial polysomnography (Embla Systems, Bloomfield, USA) was used to 
screen for sleep apnoea.  Respiratory events were scored according to the standard criteria of the 
American Association of Sleep Medicine (AASM) (Kushida et al. 2005).  An AHI of > 5/hr was 
considered abnormal and indicative of sleep apnoea.  Severity was defined as mild (AHI 5-15), 
moderate (AHI 15 – 30) or severe (AHI >30).  Participants also completed the Restless Legs Syndrome 
(RLS) Rating Scale to assess for the presence and severity of RLS (Walters et al. 2003).  This scale 
includes 10 questions each scoring 0-4 with a score of 1-10 representing mild, 11-20 moderate, 21-
30 severe and 31-40 very severe RLS.  
For objective assessment of sleep/wake cycle (circadian rhythm), subjects wore a triaxial wrist 
accelerometer (GENEActiv; Activinsights) on their non-dominant wrist for all 21 days of the study 
alongside completing a daily sleep log.  The analysis of this data has been previously described 
(Bradley, Webb-Mitchell, Hazu, Slater, Middleton, Gallagher, McAllister-Williams, & Anderson 2017).  
In brief, the accelerometer data was analysed using an open source R package sleep detection 
algorithm, GGIR, which has demonstrated a high sensitivity and specificity to detect periods of sleep 
(van Hees et al. 2015).  Sleep onset time, sleep offset time, TST, time in bed (TIB), sleep efficiency 
(defined as TST/TIB) and mean 24 hour sleep duration (defined as nocturnal sleep plus daytime 
naps) were all derived.  Correlation analysis was performed to check agreement between sleep logs 
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and accelerometer derived sleep variables.  The relative amplitude between day and night activity 
was calculated during the least active 5 hours (L5) and most active 10 hours (M10) according to 
previously published methods (Van Someren et al. 1999).  Participants were then identified as 
normal sleepers (6-10 hours sleep within 24 hours with a regular sleep wake cycle), short sleepers 
(<6 hours nocturnal sleep), long sleep (>10 hours sleep within 24 hours (Kaplan et al. 2011)) and 
circadian rhythm disturbance, including a delayed sleep phase (habitual sleep onset after 2am), 
advanced sleep phase, irregular sleep wake pattern (three to four periods of sleep but no 
consolidated overnight period) or non 24 hour pattern in keeping with the definitions within the 
International Classification of Sleep Disorder – 3rd edition (ICSD-3) (American Academy of Sleep 
Medicine 2014).  Patient reported sleep logs were used to assist in the interpretation of actigraphy 
data. 
Cognitive assessment battery 
Verbal IQ was assessed with the national Adult Reading Test (NART) (Nelson 1982) and then a range 
of tasks were administered to assess psychomotor speed, attention, and executive components of 
cognition.  This comprised of the Psychomotor vigilance Test (PVT) (Dinges and Powell 1985), the 
Attention Network Test (ANT) (Fan et al. 2002) and the Digit Symbol Substitution Test (DSST) 
(Wechsler 1981).  Participants completed two DSST’s one at the beginning of the cognitive testing 
session and one at the end of the cognitive testing session to assess for any change in performance 
across the testing session.  Reaction time (RT) data from the PVT and the ANT were fitted to an ex-
Gaussian distribution (a mathematical convolution of the Gaussian normal and exponential 
distribution).  The ex-Gaussian has been sown to approximate well to empirical RT distributions 
(Schmiedek et al. 2007); this distribution model produces three parameters: mu and sigma, the 
mean and standard deviation of the Gaussian component; and tau, which defines the exponential 
component and represents the ‘slow-tail’ of the distribution (Ratcliff 1979). To derive these 
measures, Ex-Gaussian probability density functions were fitted to the distribution of valid response 
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times of each individual using the DISTRIB toolbox (Lacouture and Cousineau 2008) in MATLAB® 
v.R2010b (The MathWorks Inc. Natick, MA).  
The Newcastle Spatial Working Memory test (Pariante et al. 2012), a test of verbal learning, TRAILS A 
and B and digit span test (Lezak et al. 2004) were also performed. Tests were performed at the same 
time of day for controls and BD patients at the end of the sleep assessment period. 
Statistical analysis 
All statistical analyses were performed using IBM SPSS statistical package version 22.  Data is 
reported as means with standard deviations.  Normality of distribution of data was tested using the 
Shapiro-Wilk test.  Log10 or square root transformations were used where necessary to normalise 
the data.  Parametric tests (e.g. t-test) were used unless the data remained non-normally distributed 
despite transformation when equivalent non-parametric tests (e.g. Mann Whitney U test) were 
used.  In the comparisons between controls and BD patients, age and NART IQ score were examined 
as possible confounders.  If there was a significant correlation of the outcome measure under 
investigation and either of these variables, then ANCOVA was performed.  Mood was not examined 
in this way due to this being significantly different between controls and BD patients.  Rather sub-
group analysis was performed taking advantage of those BD patients who were euthymic.  A score of 
< 8 on the BDI was used to define ‘euthymia’ (Keller 2003).  Note that all bipolar patients met 
euthymia criteria (YMRS < 10) with regards to manic symptoms.  Overall, there was a strong 
correlation between HAMD-17 and BDI scores (r(s)(45) = 0.831, p<0.001).  The BDI was used in 
preference to the HAMD-17 due to it containing only one sleep variable, rather than the 3 within the 
HAMD-17.  A significance threshold of p< 0.05 was used for all analyses. 
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Results 
Participants 
The participants and their sleep phenotypes have previously been described (Bradley, Webb-
Mitchell, Hazu, Slater, Middleton, Gallagher, McAllister-Williams, & Anderson 2017).  In this current 
analysis only participants with complete actigraphy and overnight sleep oximetry data sets were 
included in the analysis.  Eighty two participants, 46 with BD (16 BD I and 30 BDII) and 36 controls, 
completed the study protocol.  Table 1 shows the participant characteristics.  Groups did not differ 
significantly with regard to age or gender but participants with BD had a greater body mass index 
(BMI) and scored more highly on mood rating scales.  Twenty one participants with BD scored > 8 on 
the HAMD-17 (range 8 -35), but none of the patients were considered clinically to be in a manic or 
hypomanic episode for the duration of the study (YMRS range 0-10).  Of the 46 BD patients 28 had 
objectively defined abnormal sleep including obstructive sleep apnoea (OSA) (n=12), circadian 
rhythm sleep disorder (CRSD) (n=12), long sleep (n=14), short sleep (n=4) or a combination of these 
abnormalities.  Sixteen had normal objective measures of sleep with the absence of sleep apnoea 
confirmed with an overnight sleep study.  Two BD participants with normal accelerometry defined 
sleep patterns did not complete the overnight sleep apnoea study so were not included in the 
normal sleeping group.  On this basis, the BD patients were divided into those with objectively 
normal (n=16) and objectively abnormal sleep (n=28).  The characteristics of the various bipolar sub-
groups is shown in Table 2.  36 controls had objectively verified normal sleep without any level of 
obstructive sleep apnoea and were included in the analysis.  Two BD participants did not complete 
the full battery of cognitive tests, one who became anxious and asked to stop and the other for 
undisclosed reasons. One aged 55 years, was a normal sleeper and had a BDI score of 8. The other 
aged 25 years, was a normal sleeper with a BDI of 28. Their data is included for the tests they 
completed. 
Table 1 and 2 near here 
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Psychomotor vigilance test (PVT) 
The PVT was completed by 36 controls and 46 BD patients.  One BD patient was omitted from the 
analysis as the number of lapses committed was more than 3 times the interquartile range and they 
were deemed an extreme outlier.  As anticipated, BD patients differed from control participants 
having longer mean response times (RTs: 360 ± 50ms vs 325 ± 32ms; p <0.001; g= 0.81, 95% CI = 0.35 
– 1.26) and making more ‘lapses’ (RT > 500ms; 5.1 ± 6.4 vs 1.8 ± 2.8; p < 0.001; g = 0.64, 95% CI = 
0.19 – 1.09).  There were no missed responses made by any participant in either group.  The rate of 
‘anticipations’ (defined as responding <100ms after presentation of the target stimulus) was very 
low and did not differ between controls and BD patients (1.08 ± 1.4 vs 1.0 ± 1.3 respectively; t=0.275 
p =0.784).  As a result anticipations were not analysed further.  Mean RT and number of lapses was 
significantly greater (p = 0.047 and 0.050 respectively) in the 26 euthymic BD patients compared to 
the controls, though the effect sizes were a little smaller (g = 0.65 (95% CI= 0.13 – 1.17) and g = 0.53 
(95% CI= 0.02 – 1.05 respectively) than for the comparison including all patients.  However, the BD 
patients with normal sleep did not differ from controls on either metric, while the BD patients with 
abnormal sleep did (mean RT: p < 0.001; g = 1.18, 95% CI = 0.64 – 1.72; lapses: p < 0.001; g = 0.91, 
95% CI = 0.39 – 1.43).  This was also the case for the BD patients with abnormal sleep but who were 
euthymic (mean RT: p = 0.001; g = 1.26, 95% CI = 0.54 – 1.98; lapses: p = 0.005; g = 1.04, 95% CI = 
0.33 – 1.75).  Mean RTs are shown in the various subgroups in figure 1.  The differences from 
controls were consistent across each of the three most common BD sleep phenotypes in this cohort 
(p < 0.001 for the difference in mean RT versus controls for all three – see figure 1).  There were no 
significant correlations with age or NART IQ and so ANCOVA controlling for these variables was not 
performed. 
Figure 1 near here 
Ex-Gaussian analysis of PVT RTs found a significantly greater mu (p < 0.05; g = 0.52, 95% CI = 0.08 – 
0.97) and tau (p < 0.01, g = 0.65, 95% CI = 0.20 – 1.10), though not sigma, in BD patients compared 
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to controls.  The increase in tau is consistent with increased IIV and the higher rate of lapses seen 
with the raw RT data.  There were no significant differences from controls in either the euthymic BD 
sub-group nor the BD patients with normal sleep, in either mu, sigma or tau.  However, the BD 
patients with abnormal sleep had significantly greater mu (p < 0.01; g = 0.79, 95% CI = 0.27 -1.30), 
sigma (p < 0.005; g = 0.87, 95% CI = 0.34 -1.39) and tau (p < 0.001; g = 0.85, 95% CI = 0.33 - 1.37).  In 
the sub-group of BD patients with abnormal sleep who were euthymic, sigma and tau remained 
significantly greater than in the control participants with similar magnitude effect sizes.  Ex-Gaussian 
distributions of the PVT RTs are shown in figure 2, where it can be seen that the three common 
abnormal sleep phenotypes had similar distributions.  There were no significant correlations of age 
or NART-IQ in the control group and therefore ANCOVA controlling for these variables was not 
performed. 
Figure 2 near here 
Attention Network Task (ANT).  
The ANT was completed by 35 controls and 44 BD patients.  One control was omitted from the 
analysis as their mean RT and conflict RT were more than 3 times the interquartile range and they 
were considered an extreme outlier.  Mean ANT RTs showed a similar pattern of effects to PVT RTs, 
with BD patients having significantly greater meant RTs than controls, euthymic and BD normal 
sleepers not differing from controls, but BD abnormal sleepers having significantly greater mean RTs 
than controls (p = 0.001; g = 0.92, 95% CI = 0.40 – 1.45), including just those who were euthymic (p = 
0.002; g = 1.13, 95% CI = 0.41 – 1.85).  Ex-Gaussian analysis also revealed an identical pattern of 
effects to that seen with the PVT RT. 
The main purpose of the ANT is to assess the processing efficiency of the alerting, orientating and 
executive attentional networks (Fan, McCandliss, Sommer, Raz, & Posner 2002).  BD patients 
differed from control participants on the orientating (p < 0.05; g = 0.49; 95% CI = 0.04 – 0.95) and 
conflict (p = 0.005; g = 0.68; 95% CI = 0.22 – 1.14) RTs, the latter representing the executive network.  
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In the comparison between controls and euthymic BD patients and BD patients with normal sleep, 
the orientating RTs remained significantly different, though the conflict RTs were not significantly 
different.  However, the BD patients with abnormal sleep differed from controls on the conflict RT 
with a large effect size (p < 0.001; g = 1.14; 95% CI = 0.61 – 1.68) but with no difference in alerting or 
orientating RTs.  The euthymic BD abnormal sleepers also differed from controls on the conflict RT (p 
< 0.01; g = 1.15; 95% CI = 0.43 – 1.87) but not the other two RTs.  This finding suggests that abnormal 
BD sleepers have an impaired executive attentional network compared to controls and that is not 
dependent on mood state.  This impairment in executive attentional network was also evident in all 
three BD sleep phenotypes (p < 0.01 for all phenotypes). 
There was no correlation between age or NART IQ and mean ANT RT, conflict or orientating RT and 
so no ANCOVA was performed. 
Digit symbol substitution test (DSST) 
The DSST was completed at the beginning and end of the cognitive test battery to check for evidence 
of fatigue.  Performance on the second occasion was statistically significantly better, though with 
only a small effect size.  Only data from the first DSST to be performed is reported here, though the 
findings are identical if using the second DSST data.  The findings are shown in figure 3.  As can be 
seen, the pattern of effects in the various subgroups is very similar to that seen for the mean PVT RT 
shown in figure 1.  As expected, BD patients made fewer correct responses than the controls (p < 
0.001; g = -0.77; 95% CI = -1.22 - -0.32).  This was also the case in the euthymic BD patients (p < 0.05; 
g = -0.60; 95% CI = -1.11 - -0.08).  However, the BD patients with normal sleep did not differ from 
controls, while those with abnormal sleep did (p < 0.001; g = -0.98; 95% CI = -1.48 - -0.44), including 
just those who were euthymic (p < 0.01; g = -0.91; 95% CI = -1.61 - -0.21).  The sub-groups of BD 
patients with the three main abnormal sleep phenotypes seen also all different from controls (all p < 
0.05).  There was a significant Pearson’s correlations between age and DSST score in controls (r (36) = 
0.689, p<0.001) and patients (r (46) = 0.472, p=0.003).  Age was therefore included as a covariate in 
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ANCOVA analysis of all of the comparisons between BD patient subgroups and controls.  All 
differences remained significant. 
Figure 3 near here 
TRAILS A and B.  
One control participant was not included in this analysis as their TRAILS B-A score was greater than 3 
times the interquartile range and was therefore deemed extreme outlier. There were no significant 
differences between controls and BD patients in performance on the TRAILS A or B, or the B minus A 
score.  As a result, no subgroup analysis was performed. 
Digit span test 
There were no significant differences between controls and BD patients in performance on the digit 
span total scores.  Correlation analysis however found a significant Pearson’s correlation between 
NART-IQ and digit span score in controls (r(36) = 0.484, p=0.003) and BD patients (r(46) = 0.302, 
p=0.042).  ANCOVA was therefore performed to control for the effects of IQ.  This revealed a 
significant difference between controls and patients (F(1,78) = 5.833, p=0.018), including just those 
who were euthymic (F(1,58) = 4.159, p=0.046) but not those with normal sleep (F(1,50) = 3.355, 
p=0.073).  However, patients with abnormal sleep did differ from controls (F(1,60) = 5.165, p=0.027) 
although in this instance this was not seen in the abnormal sleepers who were euthymic (F(1,43) = 
2.717, p=0.107). 
Newcastle Spatial Working Memory (NSWM) Test 
BD patients committed significantly more between search errors on the NSWM test than controls (p 
< 0.05; g = 0.023, 95% CI = 0.07 – 0.99).  There was however a moderate correlation between age 
and between search errors in controls (r(33) = 0.562, p=0.001) and a weak correlation in BD patients 
(r(43) = 0.300, p=0.051).  After controlling for age with ANCOVA, the differences between controls and 
BD patients was no longer significant.  As a result, no further analysis was performed.  
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Verbal learning test.  
BD patients recalled significantly fewer words on the immediate recall of the verbal learning test (p = 
0.002; g= -0.60, 95% CI = -1.05 - -0.16).  There was a significant Pearson’s correlation between NART-
IQ and immediate recall score in BD patients (r(46) = 0.413, p=0.004) and a trend towards a significant 
correlation in controls after winsorisng a significant outlier (r(36) = .314, p=0.066).  ANCOVA covarying 
for NART-IQ found a significant difference between BD patients and controls (F(1,78) = 13.999, 
p<0.001), that was also seen for the euthymic (F(1,58) = 4.551, p=0.037) but not normal sleeping (F(1,48) 
= 3.681, p=0.061) subgroups.  BD abnormal sleeps, however, did differ from controls (F(1,60) = 12.806, 
p=0.001) though not just those who were in euthymia (F(1,43) = 1.982, p=0.166).   
 
Discussion 
This is the most comprehensive study to date to assess objectively defined abnormal sleep / 
circadian rhythm and cognition in BD patients compared to controls.  In summary, across a wide 
range of cognitive assessments, there were the expected significant differences between BD patients 
as a group compared to age and sex matched controls. However these differences were almost 
entirely associated with those BD patients with objectively defined abnormal sleep.  BD patients with 
normal sleep did not differ from controls on any cognitive measure with the exception of the ANT 
orientating network RTs.  Given that no corrections were made for multiple comparisons, this could 
be a type I error.  Conversely, BD patients with abnormal sleep differed from controls having longer 
PVT and mean ANT RTs, greater RT IIV, impaired executive attentional network function, fewer 
correct responses on the DSST, poorer digit span performance and worse verbal memory recall.  
While BD patients in our sample with abnormal sleep had lower mood than those with normal sleep 
(Bradley, Webb-Mitchell, Hazu, Slater, Middleton, Gallagher, McAllister-Williams, & Anderson 2017), 
BD patients with abnormal sleep but who were euthymic, also differed from the controls on all of 
these cognitive measures except digit span and verbal memory.  Given the relatively small sample 
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size of BD patients with abnormal sleep but who were in euthymia, the lack of statistical significance 
in the difference in digit span and verbal memory may well be due to a lack of statistical power.  
While we therefore confirmed cognitive dysfunction in BD, especially in measures of attention, 
rather than sleep abnormalities exacerbating such dysfunction, the cognitive abnormalities were 
entirely confined to BD patients with sleep abnormalities.  As such, these findings are therefore 
consistent with sleep disturbance being the main driver of the cognitive abnormalities seen in BD. 
Limitations 
Weaknesses of the study include a lack of the gold standard measure of sleep using video 
polysomnography.  However this was a field study and it was felt that studying patients with partial 
polysomnography in their own homes would increase compliance.  The sample was opportunistic 
with a potential bias for over-representation of patients with BD and sleep disorders, while controls 
were screened out if they suffered significant sleep problems.  A larger, more representative, sample 
size would have allowed greater sub group analysis of the differential effect of the different patterns 
of sleep and circadian rhythm.  Future studies might include those with other psychiatric disorders 
or control subjects with primary sleep disorders to study the impact upon cognition. 
Actigraphy assesses physical activity and hence is a surrogate marker of sleep.  However, it has been 
the most widely used and published technique to assess sleep/wake patterns and circadian rhythm 
for many years (Melo et al. 2016).  The American Academy of Sleep Medicine also recognise 
actigraphy as sufficient, alongside clinical evaluation, to make the diagnosis of circadian rhythm 
disorders (American Academy of Sleep Medicine 2014).  In bipolar disorder, sleep variables derived 
from actigraphy have been shown to highly correlate with gold standard polysomnography (Kaplan 
et al. 2012).  As a result, while the use of actigraphy is a limitation, we believe that it is a legitimate 
and pragmatic method for assessing sleep. 
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The patients included in this study were not medication free and it is not possible to exclude the 
possibility that this influenced our findings.  However, there was no difference in the rates of usage 
of different medications between the different bipolar subgroups with the exception of a 
significantly higher rate of hypnotic use in in long sleepers (42.9%) compared to normal sleepers 
(6.3%) (Fisher’s exact test p = 0.031).  This finding and details of the medication used is provided in 
our previous publication (Bradley, Webb-Mitchell, Hazu, Slater, Middleton, Gallagher, McAllister-
Williams, & Anderson 2017). 
No correction was made for multiple statistical testing.  However, it seems unlikely that our findings 
are type I errors for two main reasons.  Firstly, there was consistency in the findings both between 
measures of the same cognitive domain (attention – PVT and ANT) and across domains.  Secondly, if 
a conservative Bonferroni correction had been used the main bulk of our findings would have 
remained significant, including the difference between bipolar patients with abnormal sleep and 
controls (PVT RTs and lapses, ANT RT, DSST, verbal learning) and between euthymic bipolar patients 
with abnormal sleep and controls (PVT RTs and lapses, ANT RT).  The findings that would not have 
remained significant are the DSST difference between controls and euthymic bipolar abnormal 
sleepers and controls and the findings with the digit span test.  We did not apply a Bonferonni 
correction since we were not interested in whether patients and controls differed cognitively, but in 
which domain with a particular a priori focus on attention and psychomotor processing speed.  
Applying corrections for multiple comparisons would simply have increased the risk of type II errors.  
Rather we rely upon describing the statistical tests performed and the pattern of effects seen 
(Perneger 1998).  For all contrasts we include estimates of effect size with accompanying 95%CI 
which are more informative to future research that the point estimates of significance which we 
agree are linked to sample size and therefore limited in their utility. 
The study also had a number of strengths.  These include a well characterised group and 
comprehensive measures of cognition, sleep and circadian rhythm across 21 days.  The control group 
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were carefully matched and a wide range of sleep disturbances was included to reflect real life 
clinical practice where many BD patients have a variety of reasons for disturbed sleep.  We were 
fortunate enough to have a reasonable number of both normal and abnormal sleepers, and of 
euthymic patients in the latter group.  This allowed for an examination of our hypotheses without 
the need for spuriously covarying for mood in comparisons between two groups (patients and 
controls) that differed on their mood ratings. 
In conclusion we have found that many patients with BD have disrupted sleep and that this has a 
significant impact upon tests of cognition including in those patients in remission. This suggests that 
objective measures of sleep disturbance need to be taken into account in future studies of cognition 
in BD and that sleep may be a potential target for treatment of cognitive disturbance in BD. 
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Figure Legends 
Figure 1.  PVT mean response times 
Response times (mean with the error bars representing the SEM) on the PVT task for the 
healthy controls (n=36) and BD patients.  The total BD group is shown (n=45) along with sub-
sets of the BD patients including those who were euthymic (n=26); those with normal sleep 
(n=16); those with abnormal sleep (27);those with abnormal sleep who were euthymic 
(n=11); those BD patients with long sleep (n=13); those BD patients with CRSD (n=12) and 
those BD patients with OSA (n=12).  * = p < 0.05; *** = p < 0.001 compared to controls. 
BD = bipolar disorder; CRSD = circadian rhythm sleep disorder; OSA = Obstructive sleep 
apnoea; PVT = Psychomotor vigilence task; SEM = Standard error of the mean. 
Figure 2.  PVT response time distributions 
Response time distributions plotted for controls (n=36), BD patients with normal sleep 
(n=16) and BD patients with abnormal sleep (n=27).  Data plotted in Prism v7.01, 2016 
(GraphPad Software Inc, La Jolla, CA) with a smoothed curve based on a rolling average 
utilising 4 data points on each side of each data point. 
BD = bipolar disorder; PVT = Psychomotor vigilence task. 
Figure 3.  DSST performance 
Number of correct responses made in 90 seconds (mean with the error bars representing 
the SEM) for the healthy controls (n=36) and BD patients.  The total BD group is shown 
(n=46) along with sub-sets of the BD patients including those who were euthymic (n=26); 
those with normal sleep (n=16); those with abnormal sleep (28) and those with abnormal 
sleep who were euthymic (n=11) those BD patients with long sleep (n=14); those BD 
patients with CRSD (n=12) and those BD patients with OSA (n=12).  * = p < 0.05; ** = p < 
0.01; *** = p < 0.001 compared to controls. 
BD = bipolar disorder; CRSD = circadian rhythm sleep disorder; DSST = Digit symbol 
substitution test; OSA = Obstructive sleep apnoea; SEM = Standard error of the mean. 
Table 1: General characteristics of study participants at baseline (day 1) 
   Statistical test 
Characteristic Controls (n=36) Bipolar Disorder (n=46) ᵪ2(df) Mann Whitney U P value 
Female gender, n (%) 25 (69.4%) 31 (67.4%) 0.039 (1)  0.843 
Age years: mean (SD) 
(Range) 
42.8 (11.9) 
(19-64) 
46.8 (11.1) 
(23-64) 
 670.0 0.140 
NART (SD)  
(Range) 
116.5 (8.0) 
(97-128) 
119.5 (7.2) 
(97-131) 
 632.5 0.099 
Years in full time education (SD)  
(Range) 
15.3 (3.0) 
(11-22) 
15.8 (3.5) 
(10-24) 
 755.5 0.495 
BMI  mean: kg/m2 (SD) 
(Range) 
25.1 (4.4) 
(19.5-36.4) 
30.0 (6.7) 
(21.0-52.0) 
 427.0 <0.001 
BMI > 30kg/m2, n (%) 6 (17.1%) 19 (41.3%) 5.438 (1)  0.02 
Smoker, n (%) 3 (8.3%) 6 (13%) 0.459 (1)  0.724 
Mean alcohol units per week  
(range) 
8.7 (7.7) 
(0-30) 
4.9 (9.8) 
(0-50) 
 474.5 0.001 
HAMD-17 mean (SD) 
(Range) 
Remission (HAMD < 7) n (%) 
0.3 (0.6) 
(0-2) 
36 (100.0%) 
9.1 (7.2) 
(0-35) 
25 (54.3%) 
 42.0 <0.001 
BDI (SD)  
(Range) 
Remission (BDI < 8) n (%) 
0.7 (1.8) 
(0-8) 
36 (100%) 
12.2 (11.5) 
(0-49) 
24 (52.2%) 
 116.5 <0.001 
YMRS mean (SD) 
(Range) 
0.1 (0.4) 
(0-2) 
0.9 (2.2) 
(0-10) 
 728.0 0.128 
PSQI Global score mean (SD) 
(Range) 
PSQI > 5 n (%) 
2.3 (1.2) 
(0-4) 
0 (100%) 
8.6 (4.6) 
(1-18) 
30 (65.2%) 
 125.0 <0.001 
ESS mean (SD) 
(Range) 
ESS > 10 
3.8 (2.4) 
(0-9) 
0 (0%) 
6.2 (4.9) 
(0-21) 
9 (19.6%) 
 575.5 0.018 
 
Table 2:  Comparison of characteristics of participants with bipolar disorder (BD) in different sub-
groups 
      
Characteristic Euthymic BD 
Patients (n=24) 
Non-Euthymic BD 
Patients (n=22) 
BD with normal 
sleep (n=16) 
BD with abnormal 
sleep (n=28) 
Euthymic BD with 
abnormal sleep 
(n=11) 
Female gender, n (%) 17 (70.8) 14 (63.6) 12 (75.0) 19 (67.9) 8 (72.7) 
Age years: mean (SD) 47.1 (11.4) 46.1 (11.0) 44.1 (10.3) 49.2 (10.8) 50.2 (12.1) 
NART (SD)  119.9 (5.9) 119.0 (8.5) 120.4 (7.1) 119.4 (6.7) 118.5 (4.2) 
BMI  mean: kg/m2 (SD) 29.8 (7.1) 30.1 (6.4) 28.3 (4.2) 31.0 (7.8) 32.2 (8.9) 
HAMD-17 mean (SD) 4.5 (2.8) 14.1 (7.1) 5.8 (5.2) 10.1 (7.2) 5.3 (2.2) 
BDI (SD)  3.7 (2.3) 21.4 (10.4) 6.7 (7.9) 13.8 (11.5) 3.6 (1.9) 
YMRS mean (SD) 1.1 (2.6) 0.6 (1.8) 1.5 (3.1) 0.5 (1.6) 0.2 (0.4) 
PSQI Global score mean (SD) 6.4 (3.7) 11.0 (4.4) 6.6 (4.2) 9.9 (4.6) 7.9 (4.3) 
ESS mean (SD) 5.5 (4.4) 7.1 (5.3) 5.4 (3.6) 7.1 (5.4) 6.8 (5.7) 
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